Showing results (231-240 of 387) with videos related to
Sort By:
Pageof 39
Annals of Clinical and Translational Neurology|May 28, 2016
Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's diseaseNicholas S Lim, Christine R Swanson, Hua-Ren Cherng, et al.Journal of Alzheimer'S Disease : JAD|August 29, 2016
Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter CohortInger van Steenoven, Dag Aarsland, Daniel Weintraub, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 11, 2014
Conversion between mini-mental state examination, montreal cognitive assessment, and dementia rating scale-2 scores in Parkinson's diseaseInger van Steenoven, Dag Aarsland, Howard Hurtig, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2021
Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuumDuygu Tosun, Zeynep Demir, Dallas P Veitch, et al.Journal of Pharmacokinetics and Pharmacodynamics|November 28, 2015
A population pharmacokinetic model for R- and S-citalopram and desmethylcitalopram in Alzheimer's disease patients with agitationAyman Akil, Robert R Bies, Bruce G Pollock, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 24, 2017
APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's diseaseThomas F Tropea, Sharon X Xie, Jacqueline Rick, et al.Annals of Clinical and Translational Neurology|March 31, 2023
Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body diseaseKatheryn A Q Cousins, David J Irwin, Alice Chen-Plotkin, et al.Parkinsonism & Related Disorders|March 1, 2016
The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's diseaseLaura Brennan, Andrew Siderowf, Jonathan D Rubright, et al.NPJ Parkinson'S Disease|March 5, 2020
Measurement properties from the Brazilian Portuguese version of the QUIP-RSDaniela Freitas Guerra, Ana Elisa Lemos Silva, Thiago da Silva Rocha Paz, et al.The New England Journal of Medicine|July 21, 2021
Trial of Pimavanserin in Dementia-Related PsychosisPierre N Tariot, Jeffrey L Cummings, Maria E Soto-Martin, et al.Pageof 39